Reported Late Thursday March 16, RedHill Biopharma Announces Plan To Implement ADS Ratio Change From A 1 ADS-For-10 Ordinary Shares Ratio To A 1 ADS-For-400 Ordinary Share Ratio (1-For-40) On Or About March 23, 2023
RedHill Biopharma Ltd. (NASDAQ:RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it plans to implement a ratio change of the Company's